Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 5Unknown 2Active not recruiting 2Terminated 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Neoplasms 1Disease 1Acquired Immunodeficiency Syndrome 1

Interventions

Fluorouracil 80Oxaliplatin 72Leucovorin 66Irinotecan 60Capecitabine 58Bevacizumab 57Cetuximab 43Folfox protocol 22Drug Therapy 22Neoadjuvant Therapy 19HMPL-013 17Colonoscopy 17regorafenib 15apatinib 11Panitumumab 11Chemotherapy, Adjuvant 11trifluridine tipiracil drug combination 10XELOX 10Laparoscopy 10IFL protocol 10sintilimab 9raltitrexed 9Radiotherapy 9Blood Specimen Collection 9Surveys and Questionnaires 8Surgical Procedures, Operative 8tislelizumab 7pembrolizumab 7Endoscopic Mucosal Resection 7Aspirin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Colorectal Neoplasms × Occult Blood × Clear all
NCT00617071 2013-12-18

Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants

National Cancer Institute (NCI)

Phase 3 Unknown
900 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01032746 2013-12-18

Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer

National Cancer Institute (NCI)

Phase NA Unknown
1,000 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡